Alanine.

Alanine enters and leaves the amino acid pool through transamination with pyruvate, and the enzyme that runs that step, alanine aminotransferase, requires pyridoxal-5-phosphate as its cofactor. Adequate B6 status is what lets supplemental alanine be handled through normal nitrogen and glucose metabolism.

When branched-chain amino acids such as leucine are transaminated in working muscle, the amino group released is transferred onto pyruvate to form alanine, which carries that nitrogen to the liver. Leucine supplies the nitrogen and alanine is the vehicle that moves it, so the two sit on one pathway.

Alanine and glutamine are the two amino acids muscle exports in the largest amounts to move nitrogen and carbon between tissues, alanine mainly to the liver for glucose synthesis and glutamine to the gut and kidney. Supplying both covers the two normal routes rather than loading one.

Alanine and glycine are both small neutral amino acids carried by the same sodium-coupled system A and ASC transporters, so a large dose of one competes with uptake of the other at the brush border.

Serine is deaminated to pyruvate, the same three-carbon keto acid that transaminates with glutamate to form alanine, so the two amino acids move into and out of one carbon pool.

Branched-chain aminotransferase strips nitrogen from valine onto glutamate, and alanine aminotransferase then passes it to pyruvate, which is how muscle exports amino nitrogen as alanine.

Alanine reaches glucose only after its carbon skeleton passes through pyruvate carboxylase, a biotin-dependent enzyme, so biotin status sits on the gluconeogenic use of alanine.

Cysteine catabolism releases its sulfur and yields pyruvate, the same intermediate alanine transaminates with, so the two amino acids feed one three-carbon node.

Alanine gives up its amino group to alpha-ketoglutarate and becomes pyruvate. Whether that pyruvate is oxidised depends on the pyruvate dehydrogenase complex, whose E1 subunit needs thiamine pyrophosphate. This is settled biochemistry rather than a combination trial, so it describes a dependency in normal energy metabolism, not an added effect from taking the two together.

Riboflavin becomes FAD, and FAD is the electron carrier bound to dihydrolipoamide dehydrogenase inside the pyruvate dehydrogenase complex. Alanine-derived pyruvate cannot move into the citric acid cycle without that step turning over. The relationship is a cofactor dependency in normal metabolism.

Every oxidative step that pyruvate from alanine passes through hands electrons to NAD+. Niacin and its amide are the dietary precursors of that dinucleotide. Described here as a cofactor relationship in normal energy metabolism, not as an effect measured from co-supplementation.

Pyruvate dehydrogenase transfers a two-carbon acetyl unit onto coenzyme A. Pantothenic acid is the backbone of that carrier. Without it the acetyl group has nowhere to go, which is why the two nutrients sit on one pathway in normal metabolism.

Lipoic acid is bound covalently as lipoamide inside the complex that oxidises alanine-derived pyruvate, shuttling the acetyl group between subunits. Supplemental alpha-lipoic acid is not the source of that bound cofactor, so the connection describes the shared pathway rather than a dosing effect.

When the liver rebuilds glucose from alanine, pyruvate carboxylase spends ATP and PEPCK spends GTP, and both nucleotides act as magnesium complexes. Magnesium is therefore part of the machinery that lets alanine serve as a glucose precursor. A cofactor relationship, not a measured combination.

Muscle packages surplus amino nitrogen onto pyruvate as alanine and ships it to the liver. There the nitrogen enters the urea cycle, and arginine is the immediate precursor of urea in that cycle. The two amino acids meet at nitrogen handling in normal metabolism.

Alanine and proline are both substrates for sodium-dependent neutral amino acid carriers, so a large single dose of either can occupy shared transport capacity. The overlap is documented at the transporter level rather than as a measured drop in human absorption. Anyone spacing free amino acids apart is acting on that transporter logic, not on an outcome trial.

Carnosine is a dipeptide of histidine and beta-alanine, and carnosine synthase joins the two. The relevant partner here is beta-alanine, a structural isomer of L-alanine and a different molecule, so this row describes the isomer rather than L-alanine itself. Flagged because product labels often blur the two names.

The review pooled trials that gave creatine and beta-alanine together against each one alone across aerobic and anaerobic performance tests. The supplement studied was beta-alanine, the beta isomer, not L-alanine, and the two should not be read as interchangeable. Creatine loads the phosphagen system while beta-alanine raises muscle carnosine, which is why they get tested as a pair.

Beta-alanine, the beta isomer of alanine, competes with taurine for the sodium and chloride dependent taurine transporter, which is why the pairing is discussed in the sports literature. The competition is characterised at the transporter, not as a measured taurine deficit in people taking supplements. L-alanine is not the molecule in this relationship.

The two are combined in performance research because they buffer hydrogen ions in different compartments, intracellular for carnosine and extracellular for bicarbonate. Again the supplement in question is beta-alanine rather than L-alanine. Treated here as a mechanistic pairing, not as a pooled effect size.